Records containing: Primary Mitochondrial Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-15An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose, Adaptive Study of the Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
-
CLINICAL_TRIALS study record update · 2026-02-05Neurometabolic Profile of Individuals With Primary Mitochondrial Disease
-
CLINICAL_TRIALS study record update · 2026-01-22A Phase 2a Safety, Tolerability, and Pharmacodynamic Study of OMT-28 in PMD Patients With Myopathy and/or Cardiomyopathy and Inflammation (PMD-OPTION)
-
CLINICAL_TRIALS study record update · 2025-09-10Natural History Study of Mitochondrial Myopathy
-
CLINICAL_TRIALS study record update · 2021-12-17A Multicenter, Open-Label Phase 2 Extension Trial to Characterize the Long-term Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-07-07A Phase 2 Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate Safety, Tolerability, and Efficacy of Subcutaneous Injections of MTP-131 in Subjects With Mitochondrial Myopathy Previously Treated in the SPIMM-201 Study
-
CLINICAL_TRIALS study record update · 2019-04-11A Prospective Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)